Analyst Ratings for Beam Therapeutics Inc (BEAM) [Sells]
BEAM Rating Summary
BEAM Price Target Summary
- Highest: $78.00 (Guggenheim)
- Lowest: $30.00 (Jefferies)
- Average: $50.33
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$50.33 (+47.7%)
* Over Last 12-Mos
Rating Score: 4.3 / 10 Percentile Rank: 43%
Rating Score: 4.3 / 10 Percentile Rank: 43%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
1/16/2014 | Argus | N/A | Downgrade | Sell (Hold) |
N/A (N/A) |
83.18 (34.07) |
-59.04% | Details |
8/17/2012 | CLSA | N/A | New Coverage | Underperform (4) (N/A) |
60.00 (N/A) |
60.11 (34.07) |
-43.32% | Details |